We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.36B
AUM Growth
-$1.68B
Cap. Flow
-$1.45B
Cap. Flow %
-43.28%
Top 10 Hldgs %
28.65%
Holding
6,080
New
399
Increased
1,937
Reduced
2,718
Closed
947

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$274M
2
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$21.4M
3
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$20.7M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$19.1M
5
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$17.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$126M
2
NVDA icon
NVIDIA
NVDA
+$101M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$97.8M
4
MSFT icon
Microsoft
MSFT
+$89.5M
5
AMZN icon
Amazon
AMZN
+$44.3M

Sector Composition

Rank Sector Weight
1 Technology 19.97%
2 Financials 9.87%
3 Consumer Discretionary 8.34%
4 Healthcare 7.98%
5 Communication Services 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAYD icon
3801
Taylor Devices
TAYD
$178M
$9.26K ﹤0.01%
287
-46
-14% -$1.51K
NAUT icon
3802
Nautilus Biotechnolgy
NAUT
$114M
$9.26K ﹤0.01%
10,754
-2,477
-19% -$3.68K
HQI icon
3803
HireQuest
HQI
$234M
$9.26K ﹤0.01%
778
-51
-6% -$689
RAPP
3804
Rapport Therapeutics
RAPP
$2.28B
$9.25K ﹤0.01%
922
+181
+24% +$2.35K
ACDC icon
3805
ProFrac Holding
ACDC
$978M
$9.24K ﹤0.01%
1,218
-650
-35% -$4.99K
WW
3806
DELISTED
WW International
WW
$9.24K ﹤0.01%
17,679
+16,335
+1,215% +$14.2K
RDIV icon
3807
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.41B
$9.23K ﹤0.01%
189
-5,586
-97% -$274K
ATOS icon
3808
Atossa Therapeutics
ATOS
$25.9M
$9.22K ﹤0.01%
913
+17
+2% +$206
MKTW icon
3809
MarketWise
MKTW
$54.2M
$9.22K ﹤0.01%
934
-82
-8% -$982
XERS icon
3810
Xeris Biopharma Holdings
XERS
$1.57B
$9.2K ﹤0.01%
1,717
-2,218
-56% -$8.95K
CMRC
3811
Commerce.com Inc Series 1
CMRC
$181M
$9.2K ﹤0.01%
1,597
-36,039
-96% -$229K
PCYO icon
3812
Pure Cycle
PCYO
$271M
$9.18K ﹤0.01%
877
+123
+16% +$1.4K
MAZE
3813
Maze Therapeutics
MAZE
$1.51B
$9.18K ﹤0.01%
+834
New +$10K
BCYC
3814
Bicycle Therapeutics
BCYC
$273M
$9.18K ﹤0.01%
1,081
+156
+17% +$1.84K
GCTS
3815
GCT Semiconductor Holding
GCTS
$181M
$9.18K ﹤0.01%
5,596
+1,373
+33% +$2.93K
GNSS icon
3816
Genasys
GNSS
$78.8M
$9.17K ﹤0.01%
+4,041
New +$11.2K
OPBK icon
3817
OP Bancorp
OPBK
$233M
$9.17K ﹤0.01%
763
+281
+58% +$3.85K
BFLY icon
3818
Butterfly Network
BFLY
$2.35B
$9.17K ﹤0.01%
4,021
-71,114
-95% -$254K
ANRO icon
3819
Alto Neuroscience
ANRO
$1.26B
$9.15K ﹤0.01%
4,237
+1,545
+57% +$5.53K
REFI
3820
Chicago Atlantic Real Estate Finance
REFI
$260M
$9.1K ﹤0.01%
619
-2,048
-77% -$31.9K
IHRT icon
3821
iHeartMedia
IHRT
$457M
$9.09K ﹤0.01%
5,511
-3,523
-39% -$7.09K
INO icon
3822
Inovio Pharmaceuticals
INO
$113M
$9.09K ﹤0.01%
5,614
-2,876
-34% -$5.77K
AUTL
3823
Autolus Therapeutics
AUTL
$572M
$9.08K ﹤0.01%
5,857
+1,127
+24% +$2.29K
PBYI icon
3824
Puma Biotechnology
PBYI
$456M
$9.07K ﹤0.01%
3,066
-7,071
-70% -$22.1K
CPRX
3825
DELISTED
Catalyst Pharmaceutical
CPRX
$9.07K ﹤0.01%
374
-26,117
-99% -$588K
151 152
153
154 155

Similar funds

AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 44.45% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $4.11B AUM 27.59% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2025 Portfolio in Review

As of Q1 2025, Tower Research Capital (TRC) held 6,080 positions worth $3.36B, down 33% from $5.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.45B in Q1 2025, closing 947 positions and reducing 2,718 holdings. Its most notable exit was Listed Funds Trust Roundhill Magnificent Seven ETF, an estimated $8.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $18.3M.

  • Tower Research Capital (TRC)'s largest Q1 2025 buy was Vanguard S&P 500 ETF: 35,404 shares worth $18.3M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2025, an estimated $274M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2025 reduction was Apple, cutting an estimated $126M.
  • Tower Research Capital (TRC) fully exited Listed Funds Trust Roundhill Magnificent Seven ETF in Q1 2025, selling an estimated $8.86M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3.36B portfolio in Q1 2025.
  • Tower Research Capital (TRC) opened 399 new positions and closed 947 in Q1 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 33% quarter-over-quarter to $3.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.